2016年国际胰腺病学协会《自身免疫性胰腺炎治疗专家共识》解读  

Interpretation of international consensus for the treatment of autoimmune pancreatitis released by International Association of Pancreatology in 2016

作　　者：孙备[1] 冀亮[1] SUN Bei Jl Liang(Department of Pancreatic and Biliary Surgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China)

机构地区：[1]哈尔滨医科大学附属第一医院胰胆外科,黑龙江哈尔滨150001

出　　处：《中国实用外科杂志》2017年第2期153-156,共4页Chinese Journal of Practical Surgery

基　　金：国家自然科学基金项目(No.81370565;81372613)

摘　　要：自身免疫性胰腺炎(autoimmune pancreatitis,AIP)作为一种特殊类型的慢性胰腺炎,临床上常表现为梗阻性黄疸、伴或不伴胰腺实质肿块;组织学上表现为淋巴浆细胞浸润及慢性纤维化;治疗上表现出对激素类药物的高度敏感。2016年7月,国际胰腺病学协会(International Association of Pancreatology,IAP)组织相关专家共同讨论、总结,针对AIP治疗过程中的9个临床关键问题提出了共识性建议并附以治疗流程,旨在推动AIP诊治水平的进一步提升。Autoimmune pancreatitis （AIP） is a distinct form of chronic pancreatitis characterized clinically by obstructive jaundice with or without a pancreatic mass, histologically by lymphoplasmacytic infiltrate and chronic fibrosis, and therapeutically by a highly sensitive response to steroids.In July 2016, an international consensus symposium was held by International Association of Pancreatology. After a intense discussion and deliberation, an international consensus for the treatment of autoimmune pancreatitis specifically in response to 9 key clinical questions during the course of AIP and a compatible therapeutic algorithm were proposed to further improve the diagnosis and treatment of AIP.

关 键 词：自身免疫性胰腺炎 国际共识 

分 类 号：R6[医药卫生—外科学]